Hyperfine (HYPR) Revenue Growth (3y) (2024 - 2026)
Hyperfine (HYPR) Revenue Growth (3y) (2024 - 2026) Analysis & Trends
Powered by 
Peer Comparison
| # | Company | Market Cap | Enterprise Value | Gross Profit (Qtr) | Revenue Growth (3y) (Qtr) |
|---|---|---|---|---|---|
| 1 | Abbott Laboratories | 183.86 Bn | 176.56 Bn | 6.27 Bn | 4.63% |
| 2 | Stryker | 128.65 Bn | 125.78 Bn | 3.81 Bn | 8.01% |
| 3 | Medtronic | 108.75 Bn | 99.53 Bn | 6.41 Bn | 4.70% |
| 4 | Boston Scientific | 68.34 Bn | 66.89 Bn | 3.61 Bn | 15.36% |
| 5 | Edwards Lifesciences | 48.33 Bn | 44.65 Bn | 1.29 Bn | 10.52% |
| 6 | GE HealthCare Technologies | 28.35 Bn | 26.07 Bn | 1.98 Bn | 2.92% |
| 7 | Dexcom | 28.33 Bn | 27.21 Bn | 750.30 Mn | 17.14% |
| 8 | Smith & Nephew | 26.90 Bn | 26.32 Bn | - | - |
| 9 | Koninklijke Philips | 25.45 Bn | 22.33 Bn | 2.07 Bn | 0.73% |
| 10 | Hyperfine | 94.10 Mn | 52.82 Mn | 1.98 Mn | 13.99% |
Historic Data
Download Data| Date | Value |
|---|---|
| Mar 31, 2026 | 13.99% |
| Dec 31, 2025 | 54.90% |
| Sep 30, 2025 | 13.54% |
| Jun 30, 2025 | 20.71% |
| Mar 31, 2025 | 12.30% |
| Dec 31, 2024 | 74.61% |
| Sep 30, 2024 | 114.14% |
| Jun 30, 2024 | 116.46% |
| Mar 31, 2024 | 115.12% |